Repurposing sodium-glucose co-transporter 2 inhibitors (SGLT2i) for cancer treatment – A Review
Kristy T. K. Lau, Lui Ng, Jason W.H. Wong, Herbert H. Loong, Wing‐Lok Chan, Chi‐Ho Lee, Carlos King Ho Wong
Topics & Concepts
DapagliflozinCanagliflozinMedicineTolerabilityPharmacologyCancerClinical trialIn vivoDrugRepurposingOncologyDiabetes mellitusCancer researchInternal medicineBioinformaticsType 2 diabetesAdverse effectEndocrinologyBiologyBiotechnologyEcologyDiabetes Treatment and ManagementPancreatic and Hepatic Oncology ResearchNeuroendocrine Tumor Research Advances